"Specifically, the clinical study, which is on-going, found that 10% of the patients had a significant and rapid decline in kidney function over the four year study period and that PromarkerD correctly predicted 67% of these individuals." n =576
To put it into context..
From how interpreted it, if you were to open endedly guess how many people will have a rapid kidney decline.. it is in no way a 50/50 chance.
You would have a 10% probability or less chance of selecting a patient with a rapid decline as 57.6 of them out of 576 are experiencing the decline. PromarkerD is able to identify ~ 67%
Sounds like a big difference to me.
PIQ Price at posting:
71.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)